Director/PDMR Shareholding
Garry Jones, Non-Executive Chairman of KRM22 plc, purchased 49,238 ordinary shares on 18 May 2026, acquiring 32,572 shares at £0.307 and 16,666 shares at £0.300. Following these transactions, Mr. Jones now beneficially owns 511,849 ordinary shares, representing 0.9 per cent. of the company's issued share capital. This director dealing indicates confidence in the company's prospects.
Select text to share a quote on X · sign in to keep highlights & notes in your KRM notes
KRM22 plc, (AIM: KRM) the technology and software investment company that focuses on risk management for capital markets, announces that on 18 May 2026, Garry Jones, Non-Executive Chairman of the Company, purchased a total of 49,238 ordinary shares (the "Purchases") of 10 pence each in the capital of the Company ("Ordinary Shares").
Following this transaction, Garry Jones will have a beneficial interest in 511,849 Ordinary Shares representing 0.9 per cent. Of the issued share capital of the Company.
See more about KRM22 at KRM22.com
| 1 | Details of the person discharging managerial responsibilities / person closely associated | |
| a) | Name | Garry Jones |
| 2. | Reason for the Notification | |
| a) | Position/status | Non-Executive Chairman |
| b) | Initial notification/Amendment | Initial notification |
| a) | Name | KRM22 Plc |
| b) | LEI | 213800IBCSBLSLJ9OD78 |
| a) | Description of the Financial instrument, type of instrument | Ordinary Shares of 10 pence each ("Ordinary Shares") |
| Identification code | GB00BFM6WC61 | |
| b) | Nature of the transaction | Sale and purchase of Ordinary Shares |
| c) | Price(s) and volume(s) | Price(s) Volume(s) Purchase £0.307 32,572 Purchase £0.300 16,666 |
| d) | Aggregated information: · Aggregated volume · Price | See 4c) above |
| e) | Date of the transaction | 18 May 2026 |
| f) | Place of the transaction | London Stock Exchange, AIM Market (XLON) |
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.